Clinical Trial Update: A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating two regimens of mipomersen in patients with familial hypercholesterolemia and inadequately controlled LDL cholesterol; completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia
• Hypercholesterolemia

Drugs mentioned

• Mipomersen (mipomersen)

Snippet

Sponsor: Kastle Therapeutics, LLC | Conditions: Hypercholesterolemia, Heterozygous Familial | Phase 3 | Status: COMPLETED | Results posted: 2019-03-14